76 related articles for article (PubMed ID: 4656568)
1. Specifically deuterated 1-phenylisopropylamines. II. Synthesis of deuterium labelled phentermine.
Lindeke B; Cho AK; Fedorchuk M
Acta Pharm Suec; 1972 Dec; 9(6):605-8. PubMed ID: 4656568
[No Abstract] [Full Text] [Related]
2. Specifically deuterated 1-phenylisopropylamines. 3. A mass spectrometric investigation of the N-trifluoroacetamides of (plus or minus)-amphetamine, phentermine and (plus or minus)-p-methoxyamphetamine.
Lindeke B; Cho AK
Acta Pharm Suec; 1973 Jun; 10(3):171-86. PubMed ID: 4729694
[No Abstract] [Full Text] [Related]
3. Reductive synthesis of , -dimethylphenethylamine.
Marquardt FH; Edwards S
J Org Chem; 1972 Jun; 37(11):1861-3. PubMed ID: 5037451
[No Abstract] [Full Text] [Related]
4. The N-hydroxylation of phentermine (2-methyl-1-phenylisopropylamine) by rabbit liver microsomes.
Cho AK; Lindeke B; Hodshon BJ
Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):519-28. PubMed ID: 4638590
[No Abstract] [Full Text] [Related]
5. Specifically deuterated 1-phenylisopropylamines. Synthesis of deuterium labelled (+)-amphetamine, (+)-p-methoxyamphetamine and (+)-alpha-methyltyramine.
Lindeke B; Cho AK
Acta Pharm Suec; 1972 Sep; 9(4):363-72. PubMed ID: 4655348
[No Abstract] [Full Text] [Related]
6. Mass spectrometry of NBD-derivatives of some phenylethylamine derivatives. 15. Analysis of drug mixtures.
Reisch J; Alfes H; Kommert HJ; Jantos N; Möllmann H; Clasing D
Pharmazie; 1970; 25(5):331-4. PubMed ID: 5455414
[No Abstract] [Full Text] [Related]
7. [Clinical experience with the use of phenyltert-butylamine (phentermine) as an appetite depressant in the treatment of obesity].
Lobato DS; da Silveira DD
Hospital (Rio J); 1966 Nov; 70(5):1343-50. PubMed ID: 5301950
[No Abstract] [Full Text] [Related]
8. [Evaluation of an "anorexic" drug (phentermine-resin) in the treatment of obesity].
Benedetti A; Busonera G; Cattano G
Policlinico Prat; 1967 Nov; 74(48):1613-9. PubMed ID: 5611163
[No Abstract] [Full Text] [Related]
9. [New beta-phenethylamine derivatives: Synthesis and pharmacologic properties].
Casadio S; Cousse H; Mouzin G; Stenger A; Charveron M; Vilain P; Lauressergues H
Boll Chim Farm; 1978 Feb; 117(2):83-9. PubMed ID: 33685
[No Abstract] [Full Text] [Related]
10. [Effect of the anorexic agent phentermine hydrochloride on haemodynamics].
Zöller H; Rückert KH
Munch Med Wochenschr; 1973 Jul; 115(27):1244-8. PubMed ID: 4740752
[No Abstract] [Full Text] [Related]
11. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
[No Abstract] [Full Text] [Related]
12. Synthesis of Phentermine and its Derivatives.
Upadhyaya K; Shukla S; Meena BP; Dwivedi J
Curr Org Synth; 2024; 21(5):583-594. PubMed ID: 37259208
[TBL] [Abstract][Full Text] [Related]
13. [Determination of chlorphentermine, fenfluramine and related substances in urine].
Weischer ML; Opitz K
Arzneimittelforschung; 1967 May; 17(5):625-7. PubMed ID: 5631594
[No Abstract] [Full Text] [Related]
14. [Model for clinico-pharmacological experimentation with an appetite depressant. Clinical trial with a delayed-action preparation].
Strata A; Cucurachi L; Cucurachi P; Dell'anna A; Zuliani U
Clin Ter; 1968 Mar; 44(6):495-516. PubMed ID: 4899457
[No Abstract] [Full Text] [Related]
15. [Comparative evaluation of anoretics in weight reduction in obese patients].
Pietrzak J; Krotkiewski M
Pol Tyg Lek; 1971 May; 26(20):756-8. PubMed ID: 5580931
[No Abstract] [Full Text] [Related]
16. [The excretion of anorectic phenylalkylamines in the urine].
Opitz K; Weischer ML
Arzneimittelforschung; 1966 Oct; 16(10):1311-3. PubMed ID: 6014915
[No Abstract] [Full Text] [Related]
17. Metabolism of chlorphentermine and phentermine in man to yield hydroxylamino, C-nitroso- and nitro-compounds.
Beckett AH; Bélanger PM
J Pharm Pharmacol; 1974 Mar; 26(3):205-6. PubMed ID: 4151081
[No Abstract] [Full Text] [Related]
18. [Behavior of blood pressure during chronic effect of phenylalkylamines].
Kemper F
Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
[No Abstract] [Full Text] [Related]
19. Determination of amphetamine and phentermine in biological fluids.
O'Brien JE; Zazulak W; Abbey V; Hinsvark O
J Chromatogr Sci; 1972 May; 10(5):336-41. PubMed ID: 5054850
[No Abstract] [Full Text] [Related]
20. Synthesis of specifically labelled substituted beta-phenethylamines.
Lundström J; Agurell S
Acta Pharm Suec; 1970 Jun; 7(3):247-56. PubMed ID: 5431464
[No Abstract] [Full Text] [Related]
[Next] [New Search]
